Fevipiprant (QAW039) does not affect the pharmacokinetics of zidovudine, its glucuronide, and penicillin G via inhibition of UGT2B7 and/or OAT3
Autor: | Kulkarni, Swarupa, Poller, Birk, Drollmann, Anton, Shah, Bharti, Gray, Cathy, Greco, Erin, Rahmanzadeh, Gholamreza, Hanna, Imad, Weiss, H Markus |
---|---|
Zdroj: | In Pulmonary Pharmacology & Therapeutics February 2022 72 |
Databáze: | ScienceDirect |
Externí odkaz: |